Literature DB >> 17558415

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.

Patricia A Darrah1, Dipti T Patel, Paula M De Luca, Ross W B Lindsay, Dylan F Davey, Barbara J Flynn, Søren T Hoff, Peter Andersen, Steven G Reed, Sheldon L Morris, Mario Roederer, Robert A Seder.   

Abstract

CD4+ T cells have a crucial role in mediating protection against a variety of pathogens through production of specific cytokines. However, substantial heterogeneity in CD4+ T-cell cytokine responses has limited the ability to define an immune correlate of protection after vaccination. Here, using multiparameter flow cytometry to assess the immune responses after immunization, we show that the degree of protection against Leishmania major infection in mice is predicted by the frequency of CD4+ T cells simultaneously producing interferon-gamma, interleukin-2 and tumor necrosis factor. Notably, multifunctional effector cells generated by all vaccines tested are unique in their capacity to produce high amounts of interferon-gamma. These data show that the quality of a CD4+ T-cell cytokine response can be a crucial determinant in whether a vaccine is protective, and may provide a new and useful prospective immune correlate of protection for vaccines based on T-helper type 1 (TH1) cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558415     DOI: 10.1038/nm1592

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  698 in total

1.  KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.

Authors:  Yasuyuki Goto; Ajay Bhatia; Vanitha S Raman; Hong Liang; Raodoh Mohamath; Alessandro F Picone; Silvia E Z Vidal; Thomas S Vedvick; Randall F Howard; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2011-06-01

2.  Bacillus Calmette-Guérin vaccination using a microneedle patch.

Authors:  Yasuhiro Hiraishi; Subhadra Nandakumar; Seong-O Choi; Jeong Woo Lee; Yeu-Chun Kim; James E Posey; Suraj B Sable; Mark R Prausnitz
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

3.  Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses.

Authors:  Raskit Lachmann; Martha Bajwa; Serena Vita; Helen Smith; Elizabeth Cheek; Arne Akbar; Florian Kern
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression.

Authors:  Matthew J Johnson; Niklas K Björkström; Constantinos Petrovas; Frank Liang; Jason G D Gall; Karin Loré; Richard A Koup
Journal:  Vaccine       Date:  2013-12-08       Impact factor: 3.641

5.  CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation.

Authors:  Ryan W Nelson; James B McLachlan; Jonathan R Kurtz; Marc K Jenkins
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

6.  A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.

Authors:  Elizabeth S Gabitzsch; Younong Xu; Lois H Yoshida; Joseph Balint; Richard B Gayle; Andrea Amalfitano; Frank R Jones
Journal:  Immunol Lett       Date:  2008-12-13       Impact factor: 3.685

7.  HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.

Authors:  Nazma Mansoor; Thomas J Scriba; Marwou de Kock; Michele Tameris; Brian Abel; Alana Keyser; Francesca Little; Andreia Soares; Sebastian Gelderbloem; Silvia Mlenjeni; Lea Denation; Anthony Hawkridge; W Henry Boom; Gilla Kaplan; Gregory D Hussey; Willem A Hanekom
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

Review 8.  Signals for the execution of Th2 effector function.

Authors:  Deborah J Fowell
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

9.  Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.

Authors:  Ying Xu; Enzhuo Yang; Jianguang Wang; Rui Li; Guanghua Li; Guoyuan Liu; Na Song; Qi Huang; Cong Kong; Honghai Wang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

Review 10.  Viewing transplantation immunology through today's lens: new models, new imaging, and new insights.

Authors:  Alex Y Huang; W Nicholas Haining; Deborah S Barkauskas; Jay T Myers; Agne Petrosiute; Aneesah P Garrett; Karnail Singh; Kenneth R Cooke; Leslie S Kean
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-22       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.